Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Clinical trial NCT05450965 · RECRUITING
Trial details
- NCT number
- NCT05450965
- Sponsor
- University of Maryland, Baltimore
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2027-08-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.